Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
DSM reduces CO2 emissions at Sisseln vitamin facility2019-04-25
Main vitamin series outputs of Zhejiang Medicine in 20182019-04-24
Eli Lilly Sale of Antibiotics Brands to Eddingpharm2019-04-24
Chuwei to build Calcium Pantothenate Lipoic acid project2019-04-23
Kexing to build vitamin project2019-04-23
Lonza increased Nicotinamide price2019-04-17
Sulbactam Acid & Tazobactam Acid quoted prices stopped2019-04-16
Brother temporarily stopped production 2019-04-16
Xinfa is building Vitamin A powder project2019-04-16
Huabang to build Tazobactam etc. project2019-04-12
2019 Guidance Catalogue of Pharmaceutical Industry2019-04-12
China initiated antidumping investigation for imported methionine2019-04-10
Brother increased Vitamin K3 quoted prices2019-04-09
Jiangsu to largely cut the number of chemical factories2019-04-08
Yancheng Xiangshui chemical park permanently closed2019-04-05
List of Clinical Urgently Needed Overseas New Drugs (2nd Batch) Issued2019-04-04
Tianxin increased Folic Acid prices2019-04-03
Jiangxi Huabang resumed Sulbactam Acid quoted price2019-04-02
“4+7” quantity-ensured procurement is implemented2019-04-02
Drug registration preliminary review is cancelled2019-04-02
Basic medical insurance covers over 95% people2019-04-02
National Medical Insurance Drug List Adjustment2019-04-02
Many measures to speed up the launch of antitumor drugs2019-04-02
Auxiliary drug list will come soon2019-04-02
17 anticancer drugs reimbursement 256 million Yuan2019-04-02
List of first batch orphan drugs issued2019-04-02
Boehringer Ingelheim Shanghai biopharmaceutical base to expcapacity2019-04-02
Hainan can independently approve import global new drugs2019-04-02
These drugs from transnational companies are approved in 20182019-04-02
Fuxiang resumed Sulbactam Acid quoted price2019-04-01
United Laboratories penicillin sales value in 20182019-04-01
NMPA banned import of 2 APIs from India2019-03-27
共4123个 页次:23/129页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463